Point72 Asset Management L.P. Sells 235,734 Shares of Enhabit, Inc. (NYSE:EHAB)

Point72 Asset Management L.P. decreased its holdings in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 33.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 461,066 shares of the company's stock after selling 235,734 shares during the period. Point72 Asset Management L.P. owned approximately 0.92% of Enhabit worth $4,113,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in EHAB. Kent Lake Capital LLC acquired a new stake in shares of Enhabit during the first quarter worth $5,183,000. Marshall Wace LLP acquired a new stake in Enhabit during the 2nd quarter worth about $1,941,000. 8 Knots Management LLC purchased a new stake in shares of Enhabit in the 4th quarter valued at approximately $1,968,000. DekaBank Deutsche Girozentrale lifted its holdings in shares of Enhabit by 52.3% in the second quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company's stock valued at $4,306,000 after purchasing an additional 178,000 shares in the last quarter. Finally, WINTON GROUP Ltd purchased a new stake in Enhabit in the 2nd quarter worth about $955,000.

Enhabit Stock Up 0.8 %

NYSE:EHAB traded up $0.06 during mid-day trading on Thursday, reaching $7.57. The stock had a trading volume of 465,865 shares, compared to its average volume of 615,587. The stock has a market cap of $379.68 million, a P/E ratio of -4.60 and a beta of 1.82. The business's 50 day moving average is $8.47 and its 200 day moving average is $9.25. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.48 and a quick ratio of 1.48. Enhabit, Inc. has a fifty-two week low of $7.12 and a fifty-two week high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.05 by $0.02. Enhabit had a negative net margin of 0.84% and a positive return on equity of 1.61%. The company had revenue of $260.60 million for the quarter, compared to analyst estimates of $265.99 million. During the same quarter in the prior year, the business posted $0.04 EPS. As a group, sell-side analysts predict that Enhabit, Inc. will post 0.26 earnings per share for the current year.

Insider Activity

In other Enhabit news, Director Jeffrey Bolton purchased 5,000 shares of the business's stock in a transaction dated Thursday, August 22nd. The stock was bought at an average cost of $8.01 per share, for a total transaction of $40,050.00. Following the completion of the acquisition, the director now directly owns 78,877 shares in the company, valued at $631,804.77. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.90% of the company's stock.

Wall Street Analyst Weigh In

Separately, Bank of America decreased their price target on shares of Enhabit from $9.00 to $8.00 and set an "underperform" rating for the company in a report on Thursday, June 27th. One research analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. Based on data from MarketBeat.com, Enhabit presently has a consensus rating of "Hold" and an average price target of $9.35.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.